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for use in diabetes (n = 11; 13%) ), then 7 pain instruments (8%), 5 respiratory question-
naires (6%), 2 urological questionnaires (2%) and 2 treatment specific instruments 
(2%). The remaining 30 (34%) instruments covered individual conditions ranging from 
anaemia to osteoporosis. ConClusions: There are at least 88 patient’s treatment 
satisfaction/preference instruments published for possible use in clinical trials; 31 of 
which are useful for evaluating satisfaction / preference for drug therapies without 
reference to a specific therapy area. For those disease-specific measures, assessment 
of content validity and psychometric properties should be assessed before chosing 
the most appropriate measure for a given study.
PRM121
Dual Back TRanslaTion VeRsus single Back-TRanslaTion 
MeThoDology When TRanslaTing PaTienT RePoRTeD ouTcoMes (PRo)
Talbert M.1, Brandt B.A.2, McKown S.1, Gawlicki M.C.2, Heinzman A.3, Polltiz A.4
1Corporate Translations Inc., Chicago, IL, USA, 2Corporate Translations, Inc., East Hartford, CT, 
USA, 3Corporate Translations Inc., East Hartford, CT, USA, 4Corporate Translations, Inc., Chicago, 
IL, USA
objeCtives: To determine whether dual back-translators improve the transla-
tion process for Patient Report Outcomes (PRO). Methods: Four (4) PROs were 
translated using dual back-translators. The two back-translators worked indepen-
dently, possessing no knowledge of the other’s back-translation. The translated PROs 
were: a physical assessment questionnaire containing 1507 words with medical 
terminology, a physical assessment questionnaire with simple terminology con-
taining 593 words, a COPD questionnaire containing medical concepts with 713 
words, and a cancer treatment questionnaire containing colloquial terminology 
and 403 words. Instances of the following scenario were tallied during analysis: 
one back-translation accurately reflected the source, the other back-translation 
inaccurately reflected the source, but revealed an error in the forward translation. 
The same PROs were analyzed again, focusing only on one of the back-translators 
to compare the number of forward translation revisions that occur when using a 
single back-translator. Results: After analysis, 184 forward translation revisions 
occurred when using dual back-translators. 11 out of the 184 were a revision to a 
forward translation where one back-translation was correct despite the other back-
translation being incorrect. This occurred 4 times amongst Slavic family languages, 
3 times amongst Indian languages, 3 times amongst Southeast Asian languages, and 
once with Chinese. No such revisions occurred amongst Latin and Germanic lan-
guage families. After analysis of the translated PROs with just one back-translator, 
a total of 180 forward translation revisions occurred. ConClusions: A second 
back-translation improves the translation process if the readability of the text of 
higher difficulty, and if Slavic, Asian and Indian language translations are required. 
However, the low number of revisions resulting from one incorrect back-transla-
tion, while using dual back-translators, demonstrates that one back-translator is 
acceptable. Since dual back-translators revealed the need for only 4 more forward 
translation revisions than the single back-translator, the quality output is similar.
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objeCtives: To demonstrate the increased use of mobile phones to collect patient 
reported outcomes in research and to show that they are a valid method of data col-
lection. Methods: A literature search was conducted looking at articles published 
between 2009 and 2013 that referenced electronic diaries of some description. Articles 
were pulled out that specifically referenced mobile or cellular phones. Results: 
Twenty-four of out of 157 articles found specifically referenced mobile. The studies 
referenced in these articles were carried out on populations with an age range of 8 
years up to 70 and were split into 12 therapy areas including metabolic and genetic 
disorders, pain, weight management, sexual activity, respiratory and alcohol related. 
Population size ranged from 15 to 994 (mean 145.6; SD-180), and subjects reported 
for a minimum of 7 days (up to 6 reports per day) to a maximum of 365 days (mean 
107.9 days; SD-112.6). Notably, 17 out of the 24 studies allowed the subjects to use 
their own mobile phone for the reporting and 11 referenced smartphones specifi-
cally. ConClusions: All concluded that mobile phones were suited to collect data 
from subjects. It was noted that the use of mobiles was acceptable as they are used 
them in everyday life and found to be convenient; the technology was also inexpen-
sive to implement. The fact that 70.8% of the studies allowed the subjects to use their 
own mobile phones for the reporting emphasises the practicality of using mobile 
phones in patient reported outcomes. Although the mean age of all the studies was 
relatively low, the age range was very wide and researchers can be confident that 
older populations could use mobile phones to collect these data. The rapid adoption 
and technical evolution of mobile technologies and ubiquitous nature show that this 
technology is a valid means to collect patient reported outcomes.
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objeCtives: The lack of empirical and well-accepted cost-effectiveness (CE) thresh-
old is recognized as one of the most important barriers in using Health technology 
assessment (HTA) in policy decisions and this is no exception in Asia Pacific region. 
HTAsiaLink, a network of HTA organizations in Asia has embarked on first collabora-
tive research on determining the CE threshold across 4 countries in Asia Pacific region 
namely Korea, Japan, Malaysia, and Thailand. This pilot study aimed 1)to explore 
the feasibility of the instrument/methods used 2)to examine the value of a quality-
adjusted life-year (QALY) associated with improving quality of life in mild, moderate 
and severe health condition, and extending life during terminal illness. Methods: 
Five EQ-5D health states with different health severity (11121, 11212, 11323, 11223 
objeCtives: There is a variety of disease modifying drugs available for the 
treatment of multiple sclerosis (MS). These drugs are associated with different 
characteristics in key attributes such as side effects, mode of administration etc. 
The current study was carried out to assess the importance of treatment charac-
teristics for patients’ preferences in an ecologically valid design. Methods: In 
a discrete choice experiment (DCE), MS patients from 38 neurological practices 
in Germany (n= 1,153) were asked to choose the most and the least preferred 
drug (best-worst-scaling) among hypothetical multi-attribute alternatives with 
varying levels of the following key attributes: mode of administration, local and 
systemic side effects, frequency of administration, and required monitoring of the 
patient. This design (Case-3, multi-profile case) simulates a real choice situation 
between different hypothetical multi-attribute pharmaceutical treatment alterna-
tives. Results: On average, patients (~75% female) were 42 years of age with 9.6 
years of disease duration, and ~90% reporting prior experience with parenteral 
modes of administration. Count analysis (Flynn & Louviere, 1992; Orme, 2009) 
yielded that mode of administration was the most important attribute guiding 
patients’ preferences, with ‘oral application’ being most desired (selected as best 
option in 63% of the cases). Notably, the studied systemic side effects, such as 
flu-like symptoms or gastrointestinal disorders were only half as important as 
mode of administration for patients’ choice. The second most relevant attribute 
was frequency of administration, with ‘administration once a week’ being the most 
preferred attribute level (in 47% of the cases). ConClusions: Our data indicate 
that for MS patients, the most important attributes of MS disease modifying drugs 
are route of administration (oral being the number one choice by majority) and 
frequency of administration (with intake once a week being the most preferred), 
probably because these aspects meet the patients’ need for low treatment burden 
in daily life.
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objeCtives: Work-loss disability from ailments especially depression become 
shortcoming in economic development thus demands early reverts. No reliable tool 
to evaluate work-loss diability in Thai developed. We assessed reliability and validity 
of Thai version of Lam Employment Absence and Productivity Scale (LEAPS),direct 
patient report outcome subsequent to ailments. Methods: An original LEAPS 
was officially acquired,validated by language experts, distributed to field-test 
from patients age above 18 years with ailments seeking treatment at hospital. The 
scale reliability employed item-scale and inter-item consistency with standardized 
Chronbach’s alpha coefficient. The scale discrimination for patient with income or 
non-income job was determined and compared using area under curve for Receiver 
Operating Characteristics (AuROC) with Chi-square test. Results: There were 
seven main LEAPS items with five responder choices. Of 201 patients, 86(42.8%) 
male,115(57.2%) female, mean (SD)age of 39.6(15.2) years recruited from 3 hospitals. 
132(65.7%) and 69(34.3%) patients were classed in income job and non-income job 
respectively. Background education were graduate 76(38%), vocational certificate 
35(17.5%), high school 42 (21%) and primary education 42(21%). 74 (37.2%) of patients 
had been diagnosed with co-morbidities whom 13(18%) and 61(82%) were psycho-
logical and physical illness respectively. Overall 120(60%) of patients complained 
about their health problems which demanded medical treatment within one week, 
where 58(29%) reported the condition not interfere with daily activities whereas 
36(18%) indicated that the conditions were severe and needed hospitalization. 
The responder to LEAPS was 94.5%. Reliability test for overall internal consistency 
Chronbach’s alpha coefficient were 0.834 with AuROC of 0.78,95%CI:0.72-0.85. The 
AuROC for non-income generating vs income-generating group of 0.82,95%CI:0.71-
0.92 vs 0.77,95%CI:0.69-0.86 were not significant different (p= 0.528) with correspond-
ing Chronbach’s alpha coefficient of 0.811 vs 0.842 (p= 0.667). ConClusions: Thai 
version Lam Employment Absence and Productivity Scale(LEAPS) is reliable to use 
among Thai patients. The scale is robust with consistency among Thai patients with 
employment and loss productivity regardless of income-generating job and highly 
predictive for work-loss disability.
PRM120
a sysTeMaTic ReVieW oF PaTienTs’ TReaTMenT saTisFacTion anD/oR 
PReFeRence PaTienT-RePoRTeD oucoMes MeasuRes useD in clinical 
TRials
Pease S.1, Savre I.2, Rudell K.3, Perret C.2, Symonds T.4
1Pfizer Inc, Whitmore Lake, MI, USA, 2MAPI Research Trust, Lyon, France, 3Pfizer Limited, 
Tadworth, UK, 4Pfizer Ltd., Surrey, UK
objeCtives: To determine the availability of Patient Reported Outcome (PRO) 
instruments measuring Patient’s Treatment Satisfaction and/or Preference for drug 
therapies. Methods: The authors conducted a systematic review of the published 
literature using established biomedical literature databases (Medline and Embase), 
ClinicalTrials.gov as well as a PRO specific database (PROQOLID). The instruments 
identified through the various sources were selected according to specific criteria: 1) 
Include: PRO instruments of Treatment Satisfaction or Preference as a sole concept OR 
PRO instruments with at least two domains of Treatment Satisfaction or Preference; 2) 
Exclude: Evaluation of biomarker control OR No information found on the PRO instru-
ments. Results: The systematic literature review identified a total of 720 articles on 
biomedical databases and 1634 closed clinical trials on Clinicaltrials.gov. The search 
in PROQOLID identified ten PRO instruments. From an initial review, 130 instruments 
were considered of particular relevance. Upon detailed review, 88 PRO instruments 
met selection criteria - nine of which were solely designed for a specific study. Of these 
88 PRO instruments, 31 were generic (35%). The most disease-specific measures were 
